NCT05662397
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05662397
Title A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors HotSpot Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10087 United States Details
Montefiore Einstein Comprehensive Cancer Center The Bronx New York 10461 United States Details
Providence Cancer Institute of Oregon Portland Oregon 97213 United States Details
Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh (UPMC), Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Ottawa Ottawa Ontario K1N 6N5 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
NEXT Oncology Barcelona IOB Hospital Quirónsalud Barcelona Spain Details
Clínica Universidad de Navarra Madrid Spain Details
NEXT Oncology Hospital Universitario Quirónsalud Madrid Madrid Spain Details
Clínica Universidad de Navarra (Pamplona) Pamplona Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field